Correlation Between India Globalization and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both India Globalization and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining India Globalization and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between India Globalization Capital and SAB Biotherapeutics, you can compare the effects of market volatilities on India Globalization and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in India Globalization with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of India Globalization and SAB Biotherapeutics.
Diversification Opportunities for India Globalization and SAB Biotherapeutics
-0.25 | Correlation Coefficient |
Very good diversification
The 3 months correlation between India and SAB is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding India Globalization Capital and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and India Globalization is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on India Globalization Capital are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of India Globalization i.e., India Globalization and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between India Globalization and SAB Biotherapeutics
Considering the 90-day investment horizon India Globalization Capital is expected to under-perform the SAB Biotherapeutics. But the stock apears to be less risky and, when comparing its historical volatility, India Globalization Capital is 2.87 times less risky than SAB Biotherapeutics. The stock trades about -0.07 of its potential returns per unit of risk. The SAB Biotherapeutics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 303.00 in SAB Biotherapeutics on October 26, 2024 and sell it today you would earn a total of 69.00 from holding SAB Biotherapeutics or generate 22.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 97.5% |
| Values | Daily Returns |
India Globalization Capital vs. SAB Biotherapeutics
Performance |
| Timeline |
| India Globalization |
| SAB Biotherapeutics |
India Globalization and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with India Globalization and SAB Biotherapeutics
The main advantage of trading using opposite India Globalization and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if India Globalization position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.| India Globalization vs. Oragenics | India Globalization vs. vTv Therapeutics | India Globalization vs. 22nd Century Group | India Globalization vs. CV Sciences |
| SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |